Hims & Hers Health (HIMS) Cash from Financing Activities (2019 - 2026)

Hims & Hers Health (HIMS) has 8 years of Cash from Financing Activities data on file, last reported at -$77.9 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities fell 238.34% year-over-year to -$77.9 million; the trailing twelve-month figure through Mar 2026 stood at $674.8 million (up 771.03% YoY), and the FY2025 full-year result was $729.6 million, up 776.55% from the prior year.
• Cash from Financing Activities improved to -$77.9 million in Q1 2026, from -$97.5 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $889.2 million in Q2 2025 to a low of -$97.5 million in Q4 2025.
• A 5-year average of $29.4 million and a median of -$13.7 million in 2024 frame the typical range for Cash from Financing Activities.
• Across the five-year window, Cash from Financing Activities plunged 13308.97% in 2022 and jumped 3647.45% in 2025, its largest moves.
• Tracing HIMS's Cash from Financing Activities over 5 years: stood at -$10.5 million in 2022, then soared by 62.11% to -$4.0 million in 2023, then sank by 244.49% to -$13.7 million in 2024, then sank by 614.34% to -$97.5 million in 2025, then climbed by 20.14% to -$77.9 million in 2026.
• Business Quant data shows HIMS's Cash from Financing Activities at -$77.9 million in Q1 2026, -$97.5 million in Q4 2025, and -$39.0 million in Q3 2025.